Warren Buffett’s radiation treatment for prostate is complete, according to The Omaha World-Herald, a paper owned by Buffett’s Berkshire Hathaway (NYSE:BRK.B).
The 82-year-old investor disclosed that he was undergoing radiation for stage 1 prostate cancer in an April letter to shareholders. Early in the course of his disease, Buffett referred to the cancer as “not remotely life-threatening” and a “non-event.”
Buffett told a number of newspaper executives under his umbrella that, “It’s a great day for me. Today I had my 44th and last day of radiation,” the World-Herald reported.
When Buffett’s reign at Berkshire Hathaway eventually end, his current responsibilities will be split between a CEO and at least one chief investor.
While plans for Buffett’s successors have yet to be publicly announced, Buffett has apparently informed Berkshire Hathaway’s board of his preferred candidates. However, Ted Weschler and Todd Combs appear to be the leading candidates, and currently have some sway over some of Berkshire’s moves.
— Ryan Hauck, InvestorPlace